News
Santen launches Ducressa for post-cataract surgery
Santen has announced the launch of Ducressa in the UK and Ireland. The therapy is a fixed dose combination of levofloxacin and dexamethasone for use after cataract surgery.
You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.
Santen has announced the launch of Ducressa in the UK and Ireland. The therapy is a fixed dose combination of levofloxacin and dexamethasone for use after cataract surgery.